Contents
Zinoxx is a systemic antibacterial drug. Beta-lactam antibiotic used to treat bacterial infections. It is recommended in bronchitis, pneumonia, ear infections and urinary tract infections (e.g. pyelonephritis). Zinoxx is in the form of prescription film-coated tablets.
Zinoxx, Producent: Tabuk Poland
form, dose, packaging | availability category | the active substance |
coated tablets; 250 mg, 500 mg; 10 pieces | prescription drug | cefuroksym |
Zinoxx – indications for admission
Zinoxx is available with a prescription in the form of film-coated tablets, and its active substance is cefuroxime. It is used to treat the following infections caused by bacteria susceptible to cefuroxime: upper respiratory tract infections – pharyngitis, laryngitis, angina, sinusitis, lower respiratory tract infections – acute bronchitis, exacerbation of chronic bronchitis, pneumonia, otitis media, urinary tract infections – pyelonephritis, cystitis , urethritis, gonorrhea – acute uncomplicated urethritis and cervicitis, skin and soft tissue infections – e.g. furunculosis, pyoderma, impetigo, early stage of Lyme disease and prevention of its late complications in adults and children over 12 years of age .
Zinoxx and contraindications
A contraindication to the use of Zinoxx is hypersensitivity to any of the ingredients or other beta-lactam antibiotics, e.g. from the group of cephalosporins.
Dosage
Adults:
- For most infections, I use 250 mg twice a day.
- Urinary tract infections: 125 mg twice daily (pyelonephritis: 2 mg twice daily).
- Infections of the lower respiratory tract: in the case of severe or suspected pneumonia 500 mg twice a day.
- Uncomplicated gonorrhea: single dose of 1 g.
- Lyme disease in adults and children after the age of 12: 500 mg twice a day for 2 days.
In the case of treating pneumonia or exacerbation of chronic bronchitis, the doctor may use sequential therapy, in which he will first prescribe the intramuscular or intravenous administration of cefuroxime, and then the appropriate dosage of the preparation in the oral form.
Kids:
- In most infections, the usual dose is 125 mg twice daily (or 2 mg / kg body weight daily in 20 divided doses), no more than 2 mg daily.
- Otitis media in children from 3 months of age – 2 years of age: usually 125 mg twice a day (or 2 mg / kg body weight daily in 20 divided doses), no more than 2 mg a day.
- Severe infections or otitis media in children over 2 years of age: 250 mg twice a day (or 2 mg / kg body weight daily in 30 divided doses), no more than 2 mg a day.
For younger children, the use of cefuroxime oral suspension (not tablets) is recommended. There is no clinical experience with the use of the preparation in infants under 3 months of age. In elderly patients, patients with impaired renal function and those undergoing dialysis, no special precautions are necessary, as long as the daily dose does not exceed 1 g.
Use orally Zinoxx. The tablets should be taken after a meal.
Zinoxx – warnings
- Before using Zinoxx, consult your doctor and inform him if you have ever experienced hypersensitivity reactions to cephalosporins, penicillins or to other drugs or allergens.
- You should see your doctor immediately if you develop any new bacterial or fungal infections while using this medicine.
- Zinoxx may cause side effects such as dizziness, which may impair the ability to drive and use machines.
- If diarrhea occurs during or after treatment, do not treat it yourself, but see a doctor, as there is a risk of pseudomembranous enteritis, sometimes severe.
- Pregnant women may only take the medicine if the doctor deems it necessary.
- The cefuroxime in Zinoxx passes into breast milk.
Zinoxx – interactions
It is recommended to inform your doctor if you use:
- diuretics (e.g. furosemide);
- antacids;
- combined oral contraceptives;
- oral anticoagulants;
- samplesecyd.
Zinoxx – side effects
Using Zinoxx can cause: positive Coombs test, thrombocytopenia, leukopenia, vomiting, skin rashes, headache, dizziness, diarrhea, nausea and abdominal pain, transient increases in liver enzymes, drug fever, serum sickness, anaphylaxis, Jarish-Herxheimer reaction, Stevens syndrome and Johnson, toxic epidermal necrolysis.